180 related articles for article (PubMed ID: 23237339)
1. Tumour and microparticle tissue factor expression and cancer thrombosis.
Date K; Hall J; Greenman J; Maraveyas A; Madden LA
Thromb Res; 2013 Feb; 131(2):109-15. PubMed ID: 23237339
[TBL] [Abstract][Full Text] [Related]
2. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
3. Microparticles and cancer thrombosis in animal models.
Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
[TBL] [Abstract][Full Text] [Related]
4. Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays.
Hisada Y; Alexander W; Kasthuri R; Voorhees P; Mobarrez F; Taylor A; McNamara C; Wallen H; Witkowski M; Key NS; Rauch U; Mackman N
Thromb Res; 2016 Mar; 139():90-7. PubMed ID: 26916302
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.
Date K; Ettelaie C; Maraveyas A
J Thromb Haemost; 2017 Dec; 15(12):2289-2299. PubMed ID: 29028284
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.
Geddings JE; Mackman N
Blood; 2013 Sep; 122(11):1873-80. PubMed ID: 23798713
[TBL] [Abstract][Full Text] [Related]
7. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
Manly DA; Wang J; Glover SL; Kasthuri R; Liebman HA; Key NS; Mackman N
Thromb Res; 2010 Jun; 125(6):511-2. PubMed ID: 19854471
[TBL] [Abstract][Full Text] [Related]
8. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
9. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor positive microparticles as a biomarker for increased risk of breast cancer-associated thrombosis: a mini review.
Bucciol R; Othman M
Curr Opin Hematol; 2023 Sep; 30(5):180-185. PubMed ID: 37522480
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
[TBL] [Abstract][Full Text] [Related]
12. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology.
Kleinjan A; Böing AN; Sturk A; Nieuwland R
Thromb Res; 2012 Oct; 130 Suppl 1():S71-3. PubMed ID: 23026670
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine.
Yates KR; Welsh J; Echrish HH; Greenman J; Maraveyas A; Madden LA
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):680-7. PubMed ID: 21941170
[TBL] [Abstract][Full Text] [Related]
14. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers.
Bharthuar A; Khorana AA; Hutson A; Wang JG; Key NS; Mackman N; Iyer RV
Thromb Res; 2013 Aug; 132(2):180-4. PubMed ID: 23856554
[TBL] [Abstract][Full Text] [Related]
15. Role of tissue factor in venous thrombosis.
Manly DA; Boles J; Mackman N
Annu Rev Physiol; 2011; 73():515-25. PubMed ID: 20690821
[TBL] [Abstract][Full Text] [Related]
16. Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.
Gheldof D; Mullier F; Bailly N; Devalet B; Dogné JM; Chatelain B; Chatelain C
Thromb Res; 2014 Mar; 133(3):433-9. PubMed ID: 24290525
[TBL] [Abstract][Full Text] [Related]
17. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.
Campello E; Spiezia L; Radu CM; Bulato C; Gavasso S; Tormene D; Woodhams B; Dalla Valle F; Simioni P
Thromb Haemost; 2016 Jan; 115(1):81-8. PubMed ID: 26354831
[TBL] [Abstract][Full Text] [Related]
18. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year.
Thaler J; Koppensteiner R; Pabinger I; Ay C; Gremmel T
Thromb Res; 2014 Nov; 134(5):1093-6. PubMed ID: 25262106
[TBL] [Abstract][Full Text] [Related]
19. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.
Zwicker JI; Liebman HA; Neuberg D; Lacroix R; Bauer KA; Furie BC; Furie B
Clin Cancer Res; 2009 Nov; 15(22):6830-40. PubMed ID: 19861441
[TBL] [Abstract][Full Text] [Related]
20. Isolated tumour microparticles induce endothelial microparticle release in vitro.
Faulkner LG; Alqarni S; Maraveyas A; Madden LA
Blood Coagul Fibrinolysis; 2020 Jan; 31(1):35-42. PubMed ID: 31789658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]